Superstition

/
In 1948 BF Skinner put a pigeon in a box.  Unlike most of Skinner’s birds, this one did not have to learn a behavior, such as pecking a lever, to receive an edible reward. Food was automatically dispensed at fixed time intervals without fail, the pigeon simply had to wait. The fascinating development from this experiment was that after some few hours in the box the bird was performing an elaborate routine of behaviors; turns, head movements, foot raises, all presumably in an effort to bring about…

What prophylactic steps should we take to prevent DVT/PE after RARP?

/
Deep vein thromboses (DVT) and pulmonary embolism (PE) are rare, but potentially devastating, complications of major pelvic surgery. We have performed more than 1000 robot assisted radical prostatectomy (RARP) procedures in Central London (Lessons learned from 1000 RARP operations BJUI 2013;111(1):9-10.) and to date encountered just a couple of DVTs, as well as a single, non-fatal instance of PE. However, in the case of one of us (RK), a close relative passed away as a result of a PE 10 days…

The self-proclaimed King of the Urology twitter world

/
Howard Stern proclaimed himself the King of all Media; I have proclaimed myself the King of the Urology twitter world.  There is no basis for my claim.  I certainly do not have the most followers nor do I have regal heritage. If you repeat things often enough they simply become true on the web - so I'm happy to be the king What is true is that I was the first academic urologist to take to the twitterverse in a persistent, snarky, timely, and - at times- academic manner. I coached the uro-twitterati…

Editorial: Is botulinum toxin not the solution to OAB after all?

/
Dirk De Ridder Department of Urology, University Hospital Leuven, Belgium The article by Mohee et al. highlights a problem that is often neglected: the outomes we see in clinical trials do not predict the success of the therapy in real life. We know this from anticholinergics: the study results are good, but the performance in real life is much poorer. Only 20-40% will continue to take the medication. For botulinum toxin in OAB it is surprising to see that even in experienced hands only…

Ten stories of 2012, part II

Thanks for all the helpful input regarding my first blog post. Constructive criticism is always helpful, especially if I am to get better at this. If you haven't read it, part 1 is here. So, in no particular order, part 2 of 2: + Metastatic prostate cancer - it's getting complicated… 2012 was a year of hope for metastatic prostate cancer patients.  First, Enzalutamide (also known as MDV3100), in the context of a phase III RCT, was shown to prolong the survival of men with metastatic…

International Urology Journal Club on Twitter

/
International Urology Journal Club on Twitter: The Beginnings of a New Application of Social Media in Urology CME The International Urology Journal Club on Twitter almost came about by accident, although the formation of such was an inevitability. Over the course of 2012, a number of research papers have been the subjects of discussion amongst urologists on Twitter. The standout paper as example for discussion in 2012 was the PIVOT study. This generated comments that were difficult to follow…

“The most read surgical journal on the web”

/
It is an enormous privilege becoming the new Editor-in-Chief of the BJUI. As an academic it has been my ultimate dream. Thank you for this exciting opportunity to serve our readers and authors. I also wanted to express my gratitude to our editorial board and reviewers without whom this journal would not exist. Early one morning during the BAUS annual meeting 2012, I had the great pleasure of having breakfast with John Fitzpatrick. He has done wonders with the BJUI and I wish to thank and congratulate…

Twitter: my #eurekamoment #pennydrops #babyvomit

/
I remember distinctly when the penny dropped for me. It was about 2am on a warm summer’s night in early January 2012 (apologies to those of you shivering in the Northern Hemisphere). I had my one-week old son in one arm, swinging between sleeping and spewing, and an iPad in my other hand, providing distraction between nappy changes and feeds. The sleep-deprivation had dulled my senses considerably and my brain was capable of no more than light reading. It was then I read a piece in the New York…

Ten stories of 2012, part I

/
It is now my turn to welcome you to the BJUI blog. We [the editorial team] hope that you will be as excited as we are about the future. For my first blog posts, I decided to recap the year 2012 in ten stories. These are topics that caught my attention in 2012, and are certainly not representative of what others might think as 'important'. Nonetheless, I hope that you will find this curated collection of some interest, and maybe stir a little controversy or two. Happy 2013! In no particular order,…

Editorial: What have we learned from the Partin table update?

The controversies surrounding a physician’s best treatment strategy advice to an individual patient with clinically localized prostate cancer create a continuing need for advanced statistics. Historically, the Partin tables [1] were one of the first statistical tools that physicians and patients found readily usable. The tables have been updated and always focused on prediction of pathologic stage from standard clinical variables. The next commonly cited/used tool was the Kattan nomogram [2] that…
© 2021 BJU International. All Rights Reserved.